Bleeding Disorders Treatment Market - Global Outlook and Forecast 2022-2028

January 2022 | 68 pages | ID: B9E898D881BFEN
Market Monitor Global

Abstracts

Some bleeding disorders may be treated with topical products or nasal sprays. Other disorders, including hemophilia, can be treated with factor replacement therapy.

This report contains market size and forecasts of Bleeding Disorders Treatment in Global, including the following market information:

Global Bleeding Disorders Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Bleeding Disorders Treatment market was valued at 11090 million in 2021 and is projected to reach US$ 14900 million by 2028, at a CAGR of 4.3% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Hemophilia A Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Bleeding Disorders Treatment include Takeda, Bayer, Biogen, CSL Behring, Novo Nordisk, Pfizer and Grifols, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Bleeding Disorders Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Bleeding Disorders Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Bleeding Disorders Treatment Market Segment Percentages, by Type, 2021 (%)

• Hemophilia A
• Hemophilia B
• Von Willebrand Disease
• Others

Global Bleeding Disorders Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Bleeding Disorders Treatment Market Segment Percentages, by Application, 2021 (%)

• Congenital
• Acquired

Global Bleeding Disorders Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Bleeding Disorders Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Bleeding Disorders Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Bleeding Disorders Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Takeda
• Bayer
• Biogen
• CSL Behring
• Novo Nordisk
• Pfizer
• Grifols

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Bleeding Disorders Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Bleeding Disorders Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL BLEEDING DISORDERS TREATMENT OVERALL MARKET SIZE

2.1 Global Bleeding Disorders Treatment Market Size: 2021 VS 2028
2.2 Global Bleeding Disorders Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Bleeding Disorders Treatment Players in Global Market
3.2 Top Global Bleeding Disorders Treatment Companies Ranked by Revenue
3.3 Global Bleeding Disorders Treatment Revenue by Companies
3.4 Top 3 and Top 5 Bleeding Disorders Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Bleeding Disorders Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Bleeding Disorders Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Bleeding Disorders Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Bleeding Disorders Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Bleeding Disorders Treatment Market Size Markets, 2021 & 2028
  4.1.2 Hemophilia A
  4.1.3 Hemophilia B
  4.1.4 Von Willebrand Disease
  4.1.5 Others
4.2 By Type - Global Bleeding Disorders Treatment Revenue & Forecasts
  4.2.1 By Type - Global Bleeding Disorders Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Bleeding Disorders Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Bleeding Disorders Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Bleeding Disorders Treatment Market Size, 2021 & 2028
  5.1.2 Congenital
  5.1.3 Acquired
5.2 By Application - Global Bleeding Disorders Treatment Revenue & Forecasts
  5.2.1 By Application - Global Bleeding Disorders Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Bleeding Disorders Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Bleeding Disorders Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Bleeding Disorders Treatment Market Size, 2021 & 2028
6.2 By Region - Global Bleeding Disorders Treatment Revenue & Forecasts
  6.2.1 By Region - Global Bleeding Disorders Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Bleeding Disorders Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Bleeding Disorders Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Bleeding Disorders Treatment Revenue, 2017-2028
  6.3.2 US Bleeding Disorders Treatment Market Size, 2017-2028
  6.3.3 Canada Bleeding Disorders Treatment Market Size, 2017-2028
  6.3.4 Mexico Bleeding Disorders Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Bleeding Disorders Treatment Revenue, 2017-2028
  6.4.2 Germany Bleeding Disorders Treatment Market Size, 2017-2028
  6.4.3 France Bleeding Disorders Treatment Market Size, 2017-2028
  6.4.4 U.K. Bleeding Disorders Treatment Market Size, 2017-2028
  6.4.5 Italy Bleeding Disorders Treatment Market Size, 2017-2028
  6.4.6 Russia Bleeding Disorders Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Bleeding Disorders Treatment Market Size, 2017-2028
  6.4.8 Benelux Bleeding Disorders Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Bleeding Disorders Treatment Revenue, 2017-2028
  6.5.2 China Bleeding Disorders Treatment Market Size, 2017-2028
  6.5.3 Japan Bleeding Disorders Treatment Market Size, 2017-2028
  6.5.4 South Korea Bleeding Disorders Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Bleeding Disorders Treatment Market Size, 2017-2028
  6.5.6 India Bleeding Disorders Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Bleeding Disorders Treatment Revenue, 2017-2028
  6.6.2 Brazil Bleeding Disorders Treatment Market Size, 2017-2028
  6.6.3 Argentina Bleeding Disorders Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Bleeding Disorders Treatment Revenue, 2017-2028
  6.7.2 Turkey Bleeding Disorders Treatment Market Size, 2017-2028
  6.7.3 Israel Bleeding Disorders Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Bleeding Disorders Treatment Market Size, 2017-2028
  6.7.5 UAE Bleeding Disorders Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Takeda
  7.1.1 Takeda Corporate Summary
  7.1.2 Takeda Business Overview
  7.1.3 Takeda Bleeding Disorders Treatment Major Product Offerings
  7.1.4 Takeda Bleeding Disorders Treatment Revenue in Global Market (2017-2022)
  7.1.5 Takeda Key News
7.2 Bayer
  7.2.1 Bayer Corporate Summary
  7.2.2 Bayer Business Overview
  7.2.3 Bayer Bleeding Disorders Treatment Major Product Offerings
  7.2.4 Bayer Bleeding Disorders Treatment Revenue in Global Market (2017-2022)
  7.2.5 Bayer Key News
7.3 Biogen
  7.3.1 Biogen Corporate Summary
  7.3.2 Biogen Business Overview
  7.3.3 Biogen Bleeding Disorders Treatment Major Product Offerings
  7.3.4 Biogen Bleeding Disorders Treatment Revenue in Global Market (2017-2022)
  7.3.5 Biogen Key News
7.4 CSL Behring
  7.4.1 CSL Behring Corporate Summary
  7.4.2 CSL Behring Business Overview
  7.4.3 CSL Behring Bleeding Disorders Treatment Major Product Offerings
  7.4.4 CSL Behring Bleeding Disorders Treatment Revenue in Global Market (2017-2022)
  7.4.5 CSL Behring Key News
7.5 Novo Nordisk
  7.5.1 Novo Nordisk Corporate Summary
  7.5.2 Novo Nordisk Business Overview
  7.5.3 Novo Nordisk Bleeding Disorders Treatment Major Product Offerings
  7.5.4 Novo Nordisk Bleeding Disorders Treatment Revenue in Global Market (2017-2022)
  7.5.5 Novo Nordisk Key News
7.6 Pfizer
  7.6.1 Pfizer Corporate Summary
  7.6.2 Pfizer Business Overview
  7.6.3 Pfizer Bleeding Disorders Treatment Major Product Offerings
  7.6.4 Pfizer Bleeding Disorders Treatment Revenue in Global Market (2017-2022)
  7.6.5 Pfizer Key News
7.7 Grifols
  7.7.1 Grifols Corporate Summary
  7.7.2 Grifols Business Overview
  7.7.3 Grifols Bleeding Disorders Treatment Major Product Offerings
  7.7.4 Grifols Bleeding Disorders Treatment Revenue in Global Market (2017-2022)
  7.7.5 Grifols Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Bleeding Disorders Treatment Market Opportunities & Trends in Global Market
Table 2. Bleeding Disorders Treatment Market Drivers in Global Market
Table 3. Bleeding Disorders Treatment Market Restraints in Global Market
Table 4. Key Players of Bleeding Disorders Treatment in Global Market
Table 5. Top Bleeding Disorders Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Bleeding Disorders Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Bleeding Disorders Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Bleeding Disorders Treatment Product Type
Table 9. List of Global Tier 1 Bleeding Disorders Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Bleeding Disorders Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Bleeding Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Bleeding Disorders Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Bleeding Disorders Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Bleeding Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Bleeding Disorders Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Bleeding Disorders Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Bleeding Disorders Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Bleeding Disorders Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Bleeding Disorders Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Bleeding Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Bleeding Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Bleeding Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Bleeding Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Bleeding Disorders Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Takeda Corporate Summary
Table 31. Takeda Bleeding Disorders Treatment Product Offerings
Table 32. Takeda Bleeding Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Bayer Corporate Summary
Table 34. Bayer Bleeding Disorders Treatment Product Offerings
Table 35. Bayer Bleeding Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Biogen Corporate Summary
Table 37. Biogen Bleeding Disorders Treatment Product Offerings
Table 38. Biogen Bleeding Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 39. CSL Behring Corporate Summary
Table 40. CSL Behring Bleeding Disorders Treatment Product Offerings
Table 41. CSL Behring Bleeding Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Novo Nordisk Corporate Summary
Table 43. Novo Nordisk Bleeding Disorders Treatment Product Offerings
Table 44. Novo Nordisk Bleeding Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Pfizer Corporate Summary
Table 46. Pfizer Bleeding Disorders Treatment Product Offerings
Table 47. Pfizer Bleeding Disorders Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Grifols Corporate Summary
Table 49. Grifols Bleeding Disorders Treatment Product Offerings
Table 50. Grifols Bleeding Disorders Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Bleeding Disorders Treatment Segment by Type in 2021
Figure 2. Bleeding Disorders Treatment Segment by Application in 2021
Figure 3. Global Bleeding Disorders Treatment Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Bleeding Disorders Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Bleeding Disorders Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Bleeding Disorders Treatment Revenue in 2021
Figure 8. By Type - Global Bleeding Disorders Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Bleeding Disorders Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Bleeding Disorders Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Bleeding Disorders Treatment Revenue Market Share, 2017-2028
Figure 12. US Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Bleeding Disorders Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Bleeding Disorders Treatment Revenue Market Share, 2017-2028
Figure 24. China Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Bleeding Disorders Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Bleeding Disorders Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Bleeding Disorders Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Takeda Bleeding Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Bayer Bleeding Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Biogen Bleeding Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. CSL Behring Bleeding Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novo Nordisk Bleeding Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Pfizer Bleeding Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Grifols Bleeding Disorders Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)